Enhanced FAS and FASL expression levels in brain cells accompany neurodegenerative and neurological disorders’ onsets, i.e., during experimental autoimmune encephalomyelitis (EAE model), exposure to heavy metals (e.g., cadmium), as well as in Alzheimer’s disease [76,77,78]. The gene discussed is FAS; the disease is experimental autoimmune encephalomyelitis.